"While Health Canada cannot confirm when submissions are filed by a manufacturer, the department does post regular updates about submissions that have been accepted for review on the Submissions Under Review list," the regulator responded on Wednesday
J Exp Clin Cancer Res 34:71 Rosenson RS, Gandra SR, McKendrick J, Dent R, Wieffer H, Cheng LI, Catapano AL, Oh P, Kees Hovingh G, Stroes ES (2017) Identification and management of statin-associated symptoms in clinical practice: extension of a clinician survey to 12 further countries
Even though these products are tailor-made (and proven to work) on GLP-1 consumers, theyre certainly not off limits to those not using GLP-1s
People with Severe Gastrointestinal Disorders: Conditions like gastroparesis can worsen with semaglutide
There is a currently ongoing clinical trial, the SEmaglutide randomized PRAgmatic (SEPRA) trial, which will compare the effects of adding Ozempic to other antidiabetic drugs, including metformin and sulfonylureas
Target the age-appropriate reference range: IGF-1 naturally declines with age, and the goal is to restore levels to the upper quartile for your age group, not to exceed it